Emerging themes around the T-cell response & COVID-19: A look back at some of our discussions at World Vaccine Congress 2021

Table of Contents
    Add a header to begin generating the table of contents

    At the World Vaccine Congress 2021, held May 4-6, leading research and industry partners discussed the challenges and trends in the evolving COVID-19 and vaccine development landscape. In this blog, we highlight our panel discussion with Sharon Benzeno, Chief Business Development Officer and our exhibitor seminar with Harlan Robins, Chief Scientific Officer & Co-founder.

    Can adjuvants & immune profiling improve our immune response to current COVID vaccines?

    Presented by:
    Sharon Benzeno, Chief Business Development Officer, Adaptive Biotechnologies
    Ofer Levy, Director, Precision Vaccines Program, Boston Children’s Hospital, Harvard Medical School
    Tyler Martin, Chairman, President & CEO, Adjuvance Technologies
    Alessandro Sette, Center Head, Division Head, & Professor, La Jolla Institute For Allergy & Immunology
    Wolfgang Leitner, Chief Innate Immunity Section National Institute of Health-NIAID


    T-cell immune response: Exploring emerging themes in vaccine development & COVID-19 variants

    Presented by:
    Harlan Robins, PhD, CSO & Co-founder, Adaptive Biotechnologies

    Explore the cellular mechanisms underlying the response to SARS-CoV-2 with Dr. Harlan Robins, who discussed our data around COVID-19 and our work in the vaccine space. Watch on-demand now to find out more about how the immunoSEQ® Technology is driving discovery and insights in the field.


    For Research Use Only. Not for use in diagnostic procedures.

    Contact Us Contact Us
    Contact Us

    Looking for more information? Help with experimental design or technical support? Interested in speaking to someone? Contact us!

    Learn More